7,12-dihydroxymethylbenz(a)anthracene has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nandhakumar, R; Niranjali Devaraj, S; Salini, K | 1 |
| Ide, F; Ishikawa, T; Kitada, M; Kusama, K; Sakashita, H; Suka, N | 1 |
2 other study(ies) available for 7,12-dihydroxymethylbenz(a)anthracene and Experimental Neoplasms
| Article | Year |
|---|---|
Morin augments anticarcinogenic and antiproliferative efficacy against 7,12-dimethylbenz(a)-anthracene induced experimental mammary carcinogenesis.
Topics: Animals; Antioxidants; Benz(a)Anthracenes; Cell Proliferation; Cell Transformation, Neoplastic; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Animal; Neoplasms, Experimental; Oxidative Stress; Rats | 2012 |
Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benz(a)Anthracenes; Cell Transformation, Neoplastic; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Female; Gene Expression Profiling; Humans; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Receptors, Aryl Hydrocarbon; RNA, Messenger; Salivary Gland Neoplasms; Skin Neoplasms | 2004 |